LAMC2 and lung adenocarcinoma: LAMC2 expression upregulation was usually associated with worse prognosis for patients with head and neck squamous cell carcinoma (HNSC) [39], colorectal cancer[40], lung adenocarcinoma[41] and bladder cancer[42].